Hospira Gemcitabine Injection (38 mg/mL) 2 g/52.6 mL (US)

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL

제공처:

Hospira Australia Pty Ltd

INN (International Name):

Gemcitabine hydrochloride

약제 형태:

Injection, solution

구성:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; water for injections

관리 경로:

Intravenous Infusion

패키지 단위:

1 x 52.6 mL pack

수업:

Medicine Listed (Export Only)

처방전 유형:

(S1) This Schedule is intentionally blank

치료 징후:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

제품 요약:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

승인 상태:

Licence status A

승인 날짜:

2011-11-04